The Elusive Atrophic Dermatofibroma: A Rare Dermatological Enigma

Looking for the dermatofibroma dermoscopy? View our catalog to find the right dermatoscope cost ; dermoscopy actinic keratosis, and more.

Atrophic dermatofibroma represents a seldom-encountered form of dermatofibroma, which is frequently overlooked in clinical practice. This benign fibrohistiocytic tumor, while typically harmless, can pose a diagnostic challenge due to its atypical presentation. Dermatofibromas are commonly observed as nodules of skin-colored or brown hue, solitary or in multiples, predominantly on the lower legs, and exhibit a predilection for females. A key diagnostic sign is the "dimple sign," which occurs when lateral pressure is applied, revealing the epidermis's attachment to the lesion. The atrophic variant, however, is distinguished by pronounced dermal atrophy exceeding 50%, and accounts for a mere 2% of all dermatofibromas.

Discussion of the Atrophic Variant

The atrophic dermatofibroma is characterized by a subtle but significant dermal atrophy, a feature common to all dermatofibroma variants but more pronounced in this case due to the loss of elastic fibers through a process known as "elastophagocytosis" by the tumor cells. This results in an exaggerated dimpling effect upon lateral pressure, a diagnostic clue that differentiates it from other dermatofibroma variants.

Dermoscopy plays a pivotal role in differentiating atrophic dermatofibroma from melanocytic tumors, especially when the lesion presents with hyperpigmentation. The dermoscopic examination reveals a white, scar-like patch, a central plate, and a fine, regular pigmented network at the periphery, indicative of a non-melanocytic lesion. Additionally, arborizing vessels emerging from a bluish homogeneous area, giving a flame-like pattern, are observed.

The atrophic variant is marked by a flat, atrophic, or depressed surface, with histopathological features akin to common fibrous dermatofibroma, including acanthosis, basal layer hyperpigmentation, and the induction of basal cell carcinoma-like features in the epidermis, alongside the proliferation of spindle-shaped fibroblasts in the dermis. However, the central surface depression and dermal thinning are more pronounced, often with a significant reduction or absence of elastic fibers, as evidenced by specific staining techniques like van Gieson’s stain.

It is crucial to distinguish atrophic dermatofibroma from pigmented melanocytic lesions, atrophic scarring, and more aggressive conditions such as dermatofibrosarcoma protuberans to avoid misdiagnosis and ensure appropriate management.

Conclusion and Clinical Implications

The atrophic dermatofibroma, being a rare and often underdiagnosed entity, mandates a high index of suspicion, especially when encountering atrophic or sclerotic lesions in middle-aged women. Recognizing this variant is essential due to its potential for local recurrence and metastasis. Complete surgical excision followed by regular follow-up is recommended to mitigate these risks.

Declaration of Patient Consent

The authors confirm that they have secured the necessary patient consent forms. The patients have granted consent for the publication of their images and clinical information in the journal, with an understanding that their anonymity will be safeguarded to the best extent possible, although complete anonymity cannot be assured.

In summary, the atrophic variant of dermatofibroma, while infrequently diagnosed, warrants careful consideration to ensure accurate diagnosis and appropriate management, thereby optimizing patient outcomes.